Abstracts for poster presentation

IPIC 5th Edition welcomed the submission of abstracts for original contributions to the field of clinical care of primary immunodeficiencies (PIDs), until November 15th, 2021.

The Organising and Scientific Committes have carefully reviewed all abstracts and approved 133 for poster presentation.

A full list of approved abstracts can be checked below.

 

The 3 winning posters have now been identified:

1st Place: Dr TALBA CANO – ANTIBODY AND T-CELL RESPONSES FOLLOWING SARS-COV-2 VACCINATION IN PATIENTS WITH INBORN ERRORS OF IMMUNITY

2nd Place: Dr Ankur KUMAR  – CLINICAL PROFILE OF A MULTICENTRE COHORT OF PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY (CVID) FROM INDIA

3rd Place: Dr H. M. CORNELISSEN – THE HAEMATOLOGICAL FEATURES OF PRIMARY IMMUNODEFICIENCY: A RETROSPECTIVE REVIEW OF THE ROUTINE LABORATORY INVESTIGATIONS OF THE SOUTH AFRICAN PRIMARY IMMUNODEFICIENCY REGISTRY

The above mentioned winners will be awarded a monetary prize and will present their research in a dedicated congress session on April 29, 2022, in the plenary room.

Following posters ordered by presenter’s last name:

ABERUMAND B. – UNDERSTANDING ATTITUDES AND OBSTACLES TO VACCINATION AGAINST COVID-19 IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY

ADENAN A.M. – FUNCTIONAL EVALUATION OF NEUTROPHIL USING NITROBLUE TETRAZOLIUM TEST: 12 YEARS REVIEW IN A TERTIARY REFERRAL CENTRE IN MALAYSIA

AHMAD SHAWALUDIN M.Q. – A CASE REPORT CHRONIC MUCOCUTENOUS CANDIDIASIS  (CMCC) WITH MANIFESTATION OF RECURRENT INVASIVE STAPHYLOCOCCUS AUREUS INFECTION

ALBA CANO T. – ANTIBODY AND T-CELL RESPONSES FOLLOWING SARS-COV-2 VACCINATION IN PATIENTS WITH INBORN ERRORS OF IMMUNITY

ALEMAYEHU T. – CHALLENGES IN DIAGNOSING AUTO-INFLAMMATORY DISORDERS IN LOW RESOURCE SETTING

ANDREJEVIC S. – NINE-MONTH TREATMENT FOR A PATIENT WITH X-LINKED AGAMMAGLOBULINEMIA AND SARS-COV-2 INFECTION USING MULTIPLE THERAPEUTIC APPROACHES

AYGUN A. – IL12RB1 MUTATION PRESENTING WITH THE HYPER IG E SYNDROME PHENOTYPE

BAJAJ P. – NOVEL FERMT-3 GENE VARIANT IN A CHILD WITH LEUCOCYTE ADHESION DEFICIENCY TYPE-III.

BALASTEGUI H. – IDENTIFICATION OF A NOVEL NLRP12 VARIANT IN ASSOCIATION WITH A CASE OF SEVERE SARS-COV2 INFECTION

BALDRICH A. – DONOR-DERIVED T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN 3 DEFICIENCY UNDERLYING POST-TRANSPLANT INFLAMMATORY BOWEL DISEASE

BASU S. – EARLY ONSET AMYLOIDOSIS IN COPA SYNDROME:FIRST CASE REPORT

BASU S. – BILATERAL CORNEAL ULCER IN PROLIDASE DEFICIENCY – A NOVEL ASSOCIATION

BHATTARAI D. – PROFILE OF INBORN ERRORS OF IMMUNITY (IEI) IN NEPAL- EVEREST AHEAD YET TO BE SCALED

BLANCO-LOBO P. – IN VITRO EFFECT OF RUXOLITINIB ON SIGNAL-TRANSDUCER-AND-ACTIVATOR-OF-TRANSCRIPTION 1 HYPERACTIVATION IN PATIENTS WITH DOMINANT NEGATIVE STAT3 MUTATIONS

BONDARENKO A. – GENETIC LANDSCAPE OF PRIMARY IMMUNODEFICIENCIES IN UKRAINE

BRODSZKI N. – REAL-WORLD SAFETY AND TOLERABILITY OF FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN IN PEDIATRIC PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES: INTERIM ANALYSIS FROM A POST-AUTHORIZATION STUDY IN EUROPE

BUCCIOL G. – NOVEL IRF7 MUTATION IN A CHILD WITH RECURRENT PNEUMONIA

C. E. – EFFICACY AND SAFETY OF SUBCUTANEOUS HUMAN IMMUNOGLOBULIN (16.5%) IN PEDIATRIC PATIENTS WITH PRIMARY IMMUNODEFICIENCIES: DATA FROM TWO PHASE 3 STUDIES

CABAÑERO NAVALÓN M.D. – POTENTIAL ROLE OF ORAL, LUNG AND GASTROINTESTINAL MICROBIOTA IN THE PATHOPHYSIOLOGY OF COMMON VARIABLE IMMUNODEFICIENCY

CANTENYS MOLINA S. – CASE REPORT OF A POLYMORPHISM IN HOMOCYGOSIS IN THE MEFV GENE IN THE CONTEXT OF AN AUTOINFLAMMATORY SYNDROME

CARRABBA M. – HUMORAL RESPONSE TO ANTI-SARS-COV-2 VACCINATION IN PRIMARY ANTIBODY DEFICIENCIES PATIENTS

CAVALLO A. – SELECTIVE IMMUNOGLOBULIN A DEFICIENCY IN ASSOCIATION WITH BURKITT´S LYMPHOMA

CENGIZ H. – CASE REPORT: COMMON VARIABLE IMMUNE DEFICIENCY WITH THE SAME GENOTYPE AND TWO DIFFERENT CLINICS SEEN IN TWO SIBLINGS

CORNELISSEN H.M. – THE HAEMATOLOGICAL FEATURES OF PRIMARY IMMUNODEFICIENCY: A RETROSPECTIVE REVIEW OF THE ROUTINE LABORATORY INVESTIGATIONS OF THE SOUTH AFRICAN PRIMARY IMMUNODEFICIENCY REGISTRY

DAS J. – EVALUATION OF INBORN ERRORS OF IMMUNITY IN CHILDREN WITH SUSPECTED MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE

DE FELIPE B. – FIRST PROSPECTIVE PILOT STUDY OF SIMULTANEOUS NEONATAL SCREENING FOR SEVERE COMBINED IMMUNODEFICIENCIES AND SPINAL MUSCULAR ATROPHY

DE LA FUENTE MUNOZ E. – NOVEL STIM1 MUTATION

DELAFONTAINE S. – PATHOGENIC VARIANT IN TLR3 IN TWIN GIRLS WITH VIRAL ENCEPHALITIS AND OVERWHELMING INFLAMMATION

DHUNGEL S. – IMMUNOLOGICAL ABNORMALITIES IN CHILDREN PRESENTING WITH DISSEMINATED STAPHYLOCOCCUS INFECTION. A SINGLE UNIT EXPERIENCE FROM NORTH INDIA

DÍAZ M.D.L.M. – LATE DIAGNOSIS OF COMMON VARIABLE IMMUNODEFICIENCY (CVID): A PENDING PROBLEM

DÍAZ M.D.L.M. – CASE REPORT OF AUTOINMUNE THROMBOPENIA AND NEUTROPENIA IN ASSOCIATION TO AUTOINFLAMMATORY CLINICAL MANIFESTATIONS

DÍEZ J.M. – ANTIBODIES AGAINST COMMON HUMAN CORONAVIRUSES IN PLASMA AND IGG IMMUNOGLOBULIN MEDICINAL PRODUCTS

ERRAMI A. – MONOGENIC SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES IN MOROCCAN PEDIATRIC PATIENTS

FERRANTI A.C. – CASE REPORT. NEW DIAGNOSTIC OF A 65-YEAR-OLD WOMAN WITH PAUCISYMPTOMATIC COMMON VARIABLE IMMUNODEFICIENCY (CVID) WITH VERY LOW LEVELS OF IGG (50 MG/DL), BUT NORMAL LEVELS OF IGA AND IGM

FERREIRA RAMOS B.C. – A FIRST LOOK AT THE NEWBORN SCREENING FOR INBORN ERRORS OF IMMUNITY IN SAO PAULO, BRAZIL

GAJARDO R. – HYPERIMMUNE IMMUNOGLOBULIN TO SARS-COV-2 HAS HIGH CAPACITY TO NEUTRALIZE WUHAN ORIGINAL WILD-TYPE VIRUS AND VIRUS VARIANTS OF CONCERN

GALLÓN DUQUE A. – SUBCUTANEOUS IMMUNOGLOBULIN REPLACEMENT THERAPY IN SECONDARY HYPOGAMMAGLOBULINEMIA DUE TO NEPHROTIC SYNDROME

GANGADHARAN H. – NEONATAL ONSET MULTISYSTEM INFLAMMATORY DISEASE (NOMID)- A SERIES OF TWO PATIENTS FROM A TERTIARY CARE CENTER IN NORTH INDIA

GANGADHARAN H. – PRIMARY IMMUNODEFICIENCY DISORDERS PRESENTING WITH AUTOIMMUNE MANIFESTATIONS IN THE ADULT INTERNAL MEDICINE WARD OF A TERTIARY CARE CENTRE IN SOUTH INDIA- A CASE SERIES

GARCIA-BUSTOS V. – INTEGRATING CLINICS, LABORATORY, AND IMAGING FOR THE DIAGNOSIS OF COMMON VARIABLE IMMUNODEFICIENCY-RELATED GRANULOMATOUS-LYMPHOCYTIC INTERSTITIAL LUNG DISEASE

GARCIA-MARTÍNEZ E. – IDENTIFICATION OF HETEROZYGOUS PSPIP1 AND WAS VARIANTS IN A PATIENT WITH RECURRENT INFECTIONS AND INFLAMMATORY-ASSOCIATED SYMPTOMS

GEBEYEHU N. – MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES IN A THIRTEEN YEAR OLD ETHIOPIAN GIRL WITH AUTOSOMAL DOMINANT INTERFERON GAMA RECEPTOR ONE DEFECT

GILL S. – QUANTITATIVE SERUM IMMUNOGLOBULIN AS AN ASSESSMENT OF ANTIBODIES DEFECT IN A TERTIARY REFERRAL CENTRE IN MALAYSIA

GLADIATOR A. – MANUAL ADMINISTRATION OF SUBCUTANEOUS IMMUNOGLOBULIN 20% IN CLINICAL PRACTICE IN PATIENTS WITH IMMUNODEFICIENCIES

GLADIATOR A. – TRANSITIONING SUBCUTANEOUS IMMUNOGLOBULIN 20% THERAPIES IN PATIENTS WITH PRIMARY AND SECONDARY IMMUNODEFICIENCIES: A CANADIAN REAL-WORLD STUDY

GOLWALA Z. – NON-TRAUMATIC FRACTURES AND OSTEOSARCOMA YEARS AFTER HAEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PRIMARY IMMUNODEFICIENCY REVEAL UNEXPECTED DIAGNOSIS OF OSTEOGENESIS IMPERFECTA

GÓMEZ J. – HIGH DOSE IVIG IN SELECTED HIGH RISK PATIENTS WITH SEVERE COVID19 NEUMONIA

GÓMEZ-PÉREZ J. – GENOMIC RESULTS OF A PAEDIATRIC PATIENT WITH CENTRAL NERVOUS SYSTEM LYMPHOMA

GUISADO HERNÁNDEZ P. – TREATMENT OF AN IMMUNOLOGIC DOUBLE TROUBLE. JAK1/2INHIBITION IN CHILD WITH STAT1 GOF AND TRISOMY 21

HANITSCH L.G. – FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN TREATMENT IN PATIENTS WITH PRIMARY AND SECONDARY IMMUNODEFICIENCIES: THE FIGARO STUDY

HOWLEY E. – EDUCATING AND EMPOWERING PATIENT FAMILIES THROUGH DIGITALLY DESIGNED INFORMATION UNIQUE TO THE EUROPEAN THYMUS TRANSPLANTATION PROGRAMME

IGBOEKWE E. – PEGYLATED RECOMBINANT ADENOSINE DEAMINASE (ELAPEGADEMASE) MAINTAINS DETOXIFICATION AND LYMPHOCYTE COUNTS IN PATIENTS WITH ADENOSINE DEAMINASE-DEFICIENT SEVERE COMBINED IMMUNODEFICIENCY

IJSPEERT H. – CLINICAL HETEROGENEITY IN A FAMILY WITH A GAIN-OF-FUNCTION VARIANT IN IKBKB: DOES SP110 FUNCTION AS A MODIFIER GENE?

IOAN A. – AUTOIMMUNITY AND AUTOINFLAMMATION IN ROMANIAN PRIMARY IMMUNODEFICIENCY PEDIATRIC PATIENTS: RETROSPECTIVE ANALYSIS

ITURRIETA-ZUAZO I. – SARS-COV-2 PNEUMONIA IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY: CLINICAL EXPERIENCE WITH CONVALESCENT PLASMA

JIMÉNEZ GARCIA C. – THE CHALLENGES OF DIAGNOSING PRIMARY IMMUNODEFICIENCY SPOTTED AFTER B-CELL LYMPHOPROLIFERATIVE MALIGNANCY

JINDAL A. – CLINICAL PROFILE OF A MULTICENTRE COHORT OF PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY (CVID) FROM INDIA

JINDAL A. – CLINICAL PROFILE OF A LARGE SINGLE CENTER COHORT OF HEREDITARY ANGIOEDEMA FROM NORTH INDIA

KARACA N. – MID-REGIONAL PROADRENOMEDULLIN (MR-PROADM) LEVELS IN PRIMARY IMMUNODEFICIENCIES COMPLICATED WITH PULMONARY MANIFESTATIONS

KARIM A. – IL-6 MEDIATED STAT3:NFKB SIGNALLING CASCADE IN LOSS OF FUNCTION STAT3 HYPER IGE SYNDROME PATIENT: CROSSTALK, DYNAMICS & SIGNAL INTEGEARTION

KASAP N. – A CASE OF STAT5B GOF WITH A NEW STAT5B MUTATION PRESENTING WITH TREATMENT-RESISTANT SEVERE ATOPIC DERMATITIS

KAUR A. – UTILITY OF MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION FOR DETECTING COPY NUMBER VARIATIONS IN PRIMARY IMMUNODEFICIENCY DISEASE

KAUR A. – GENETIC PROFILE OF HEREDITARY ANGIOEDEMA IN A SINGLE CENTRE COHORT FROM NORTH INDIA

KAUR S. – AIHA IN WISKOTT-ALDRICH SYNDROME

KHAN S.R. – SERUM IMMUNOGLOBULINS AND PNEUMONIA RISK AND LUNG FUNCTION IN MIDDLE-AGED AND ELDERLY INDIVIDUALS: A POPULATION-BASED STUDY

KHOREVA A. – EFFICACY AND SAFETY OF ROMIPLOSTIM IN TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH WISKOTT-ALDRICH SYNDROME

KÖPPEN J. – COMBINED IMMUNODEFICIENCY IN A PATIENT WITH KABUKI SYNDROME

KOSTINOVA A. – HUMORAL IMMUNE RESPONSE AFTER ONE AND TWO DOSES OF ADJUVANTED INFLUENZA VACCINE IN PATIENTS WITH COMMON VARIABLE IMMUNE DEFICIENCY

LOGANATHAN S.K. – MALIGNANCIES  IN CHILDREN WITH INBORN ERRORS OF IMMUNITY – OUR EXPERIENCE AT CHANDIGARH, INDIA

LOPEZ MORENO N.V. – CONGENITAL NEUTROPENIA DUE TO HOMOZYGOUS MUTATION IN GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT 3 DIAGNOSED IN AN ADULT

LÓPEZ-NEVADO M. – A NOVEL PATIENT WITH COMPLETE STAT2 DEFICIENCY PRESENTED WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND IMPAIRED IFN-A SIGNALING

LÓPEZ-NEVADO M. – NOVEL MUTATIONS IN THE TET2 GENE IN TWO UNRELATED PATIENTS WITH AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME-LIKE (ALPS-LIKE) PHENOTYPE AND SUSCEPTIBILITY TO HEMATOLOGIC MALIGNANCY

LÓPEZ-NEVADO M. – PRIMARY IMMUNE REGULATORY DISORDERS WITH AN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME-LIKE PHENOTYPE: IMMUNOLOGIC EVALUATION, EARLY DIAGNOSIS, AND MANAGEMENT

LOTFY S. – A 14-YEAR-OLD BOY WITH SEVERE COMBINED IMMUNODEFICIENCY

MAHLAOUI N. – REAL-WORLD EVIDENCE IN PATIENTS WITH PRIMARY IMMUNO-DEFICIENCIES (PID): LEARNINGS FROM THE ECONOMHYQ STUDY, A FRENCH NATIONAL COHORT

MANDASARI A.A. – DIVERSE PHENOTYPES IN MICE CARRYING NOVEL LEU387ARG GAIN-OF-FUNCTION VARIANT IN SIGNAL TRANSDUCER ACTIVATOR TRANSCRIPTION 3

MARCUS N. – DEVELOPMENT OF A NOVEL BTK LENTIVIRAL VECTOR FOR GENE THERAPY OF X-LINKED AGAMMAGLOBULINEMIA

MARKELJ G. – A SLOVENIAN EXPERIENCE OF NETHERTON SYNDROME PATIENTS IN THE LAST 30 YEARS

MARKELJ G. – USE OF VIRUS SPECIFIC T CELLS FOR EBV+ LYMPHOPROLIFERATION PRETRANSPLANTATION IN AN ARPC1B DEFICIENT PATIENT

MASLE-FARQUHAR E. – OVERACTIVE STAT3 DRIVES ABERRANT ACCUMULATION OF AUTOIMMUNE-ASSOCIATED CD21LOW CD23LOW B CELLS

MEJÍA M. – NEUTRALIZING ANTIBODIES AFTER MRNA-1273 VACCINATION IN A COHORT OF PATIENTS WITH INBORN ERRORS OF IMMUNITY

MILITO C. – THE IMPACT OF SARS-COV-2 INFECTION IN PATIENTS WITH INBORN ERRORS OF IMMUNITY: THE EXPERIENCE OF THE ITALIAN NETWORK FOR PRIMARY IMMUNODEFICIENCY (IPINET)

MOHAMED MOHAMED K. – CELLULAR AND HUMORAL RESPONSES TO SARS-COV-2 VACCINE IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY

MONCAYO MUÑOZ A.P. – LONG-TERM SURVIVAL IN A PATIENT WITH COMMON VARIABLE IMMUNODEFICIENCY AFTER LUNG TRANSPLANTATION: POSSIBLE ROLE OF A HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN PROTOCOL

MOUNDIR A. – 10 YEARS OF MOROCCAN EXPERIENCE IN THE GENETIC DIAGNOSIS OF PRIMARY IMMUNODEFICIENCIES

MUNTEANU A.N. – EXTENDED LYMPHOCYTE IMMUNOPHENOTYPING FOR IMMUNODIAGNOSIS  OF RECURRENT RESPIRATORY INFECTIONS IN THE ABSENCE OF PRIMARY IMMUNODEFICIENCY

NAGY A. – LONG-TERM SAFETY OF FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN: FINAL RESULTS FROM A POST-AUTHORIZATION STUDY

NASRULLAYEVA G. – SKIN DISORDERS AND IMMUNOLOGICAL FEATURES IN AZERBAIJANI PATIENTS WITH HYPER IGE SYNDROME

NDIAYE DIOP M.T. – DERMATOLOGICAL MANIFESTATIONS DURING PRIMARY IMMUNE DEFICIENCY IN DARK SKIN

NG K.F. – THE MULTIFACETED SYNDROMIC IMMUNODEFICIENCIES: A SINGLE INSTITUTION’S 15-YEAR EXPERIENCE

NIROUEI M. – MONOGENIC DISORDER ASSOCIATED WITH AUROIMMUNE LYMPHPPROLIFERATIVE SYNDROME -LIKE PHENOTYPE

O’FARRILL P. – COMMON VARIABLE IMMUNODEFICIENCY IN ADULTS PATIENTS AND LIVER DISORDERS

PALAZZO D. – GATA2 DEFICIENCY AND HIDRADENITIS SUPPURATIVA IN A YOUNG ADULT: A THERAPEUTIC CHALLENGE

PANG F. – PATIENT- AND CAREGIVER-REPORTED QUALITY OF LIFE AND BURDEN OF DISEASE IN WISKOTT-ALDRICH SYNDROME (WAS): FINDINGS FROM A MULTINATIONAL SURVEY

PUIG-NAVARRO C. – USE OF IMMUNOGLOBULIN REPLACEMENT THERAPY: REAL-LIFE EXPERIENCE OF AN  IMMUNODEFICIENCY UNIT

RAWAT A. – PITFALLS OF TARGETED NEXT GENERATION SEQUENCING FOR DIAGNOSIS OF INBORN ERRORS OF IMMUNITY: PRELIMINARY EXPERIENCE FROM A TERTIARY CARE CENTRE AT CHANDIGARH, NORTH INDIA

RIKHI R. – GENETIC PROFILE OF CHILDREN WITH AUTOIMMUNE MANIFESTATIONS IN WISKOTT-ALDRICH SYNDROME

ROBERTA A.D.P – SURVEY RESULTS FOR HEALTH PROFESSIONALS ON INBORN ERRORS OF IMMUNITY IN ARGENTINA

ROMERO C. – SURVEILLANCE OF ANTI-SARS-COV-2 ANTIBODIES IN HEALTHY DONORS PLASMA POOLS AND INTRAVENOUS IMMUNOGLOBULIN PRODUCTS. A CONTINOUS PROGRAM FROM MAY 2020

SACHSENMAIER C. – I.MUNE NEO – A NEW TEST FOR EPIGENETIC IMMUNE CELL QUANTIFICATION IN NEWBORNS

SANCHI – PATIENTS WITH X-LINKED AGAMMAGLOBULINEMIA (XLA) MAY HAVE T CELL PROLIFERATION ABNORMALITIES: OUR EXPERIENCE AT CHANDIGARH, INDIA

SANCHI – AUTOIMMUNE MANIFESTATIONS IN A LARGE MULTI-CENTRE COHORT OF PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY IN INDIA

SEALFON A. – A NOVEL APPROACH TO CUSTOMIZING THE FLOW PROFILE FOR THE ADMINISTRATION OF SUBCUTANEOUS IMMUNOGLOBINS FOR INDIVIDUAL INFUSIONS WITH BENEFITS TO MINIMIZE OR ELIMINATE SITE REACTIONS—A CASE STUDY

SEIF F. – GENETIC DEFECTS IN INNATE AND ADAPTIVE IMMUNITY

SEMERARO M. – SUSTAINED CLINICAL IMPROVEMENT IN THREE PATIENTS AFFECTED BY ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) TREATED BY THE SELECTIVE PI3KDELTA INHIBITOR LENIOLISIB

SERRA I. – ACTIVATED PI3K-DELTA SYNDROME, AN IMMUNODEFICIENCY DISORDER, LEADS TO SENSORIMOTOR DEFICITS RECAPITULATED IN A MURINE MODEL

SHA A. – MEASURING TREATMENT SATISFACTION IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES RECEIVING IMMUNOGLOBULIN INFUSIONS

SHARIFINEJAD N. – THE FIRST PATIENT FROM THE NATIONAL IRANIAN REGISTRY WITH PROTEIN KINASE C-DELTA DEFECT, AND REVIEW OF THE LITERATURE

SHARMA K. – CROSS-TALK BETWEEN NOX AND AUTOPHAGY TO MAINTAIN THE LONG-TERM B CELL MEMORY IN PATIENTS WITH CHRONIC GRANULOMATOUS DISEASE

SIDDIQUE S. – DISEASE BURDEN FOR PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES – A COMPARATIVE STUDY

SIDDIQUE S. – IDENTIFYING CHILDREN WITH PRIMARY IMMUNODEFICIENCY DISORDERS FOR DEVELOPING EFFECTIVE PREVENTION STRATEGIES : EVIDENCE FROM SOUTH INDIA

SIL A. – UNUSUAL PRESENTATION OF AN UNCOMMON PRMARY IMMUNODEFICIENCY

SOLIS L. – PID LIFE INDEX: THE TOOL MEASURING THE GLOBAL PID ENVIRONMENT

SOLIS L. – SCREEN4RARE: ADVOCATING FOR IMPROVED EU COOPERATION IN THE FIELD OF NEONATAL SCREENING

SUDHAKAR M. – X-LINKED LYMPHOPROLIFERATIVE SYNDROME: EXPERIENCE FROM A TERTIARY CARE CENTER FROM NORTH INDIA

SUDHAKAR M. – DEFICIENCY OF ADENOSINE DEAMINASE 2: MYRIAD FACES IN A SINGLE FAMILY

SUDHAKAR M. – MONOGENIC AUTOIMMUNE HEMOLYTIC ANEMIA: EXPERIENCE FROM A TERTIARY CARE CENTER FROM NORTH INDIA

TABINI M. – NURSES MANAGEMENT OF PATIENTS WITH INBORN ERROR OF IMMUNITY DURING COVID-19 PANDEMIC IN MILAN, ITALY

TAHIAT A. – THE OCCURRENCE OF AUTOIMMUNE DISEASES IN ALGERIAN PATIENTS WITH HOMOZYGOUS MUTATIONS IN RAG1 AND RAG2

TEIXEIRA C. – HYPOGAMMAGLOBULINEMIA AND TRICHOTHIODISTROPHY: AN UNEXPECTED ASSOCIATION?

TOPYILDIZ E. – A NOVEL MUTATION IN A TURKISH CHILD PRESENTED WITH HIGH IGM LEVELS AT ADMISSION AND DIAGNOSED AS XLA FOR A LONG TIME

TROPPER L. – THE CARE-FOR-RARE CHILD LIFE SPECIALIST PROGRAM – A MODEL TO IMPLEMENT THE PRINCIPLES OF THE UNITED NATION CONVENTION ON CHILDREN’S RIGHTS INTO PEDIATRIC CLINICAL CARE

TYAGI R. – IS MORTALITY AVOIDABLE IN PATIENTS WITH HEREDITARY ANGIOEDEMA IN THE 21ST CENTURY?: A DEVELOPING COUNTRY PERSPECTIVE

TYAGI R. – GENETIC BASIS OF COMMON VARIABLE IMMUNODEFICIENCY (CVID): A MULTICENTRE EXPERIENCE FROM INDIA

VAN STIGT A. – SOLUBLE SURFACE MOLECULES IN SERUM SUGGEST INVOLVEMENT OF ACTIVATED T-CELLS AND MACROPHAGES IN NON-INFECTIOUS COMLICATIONS IN CVID

VARGAS CELY F.S. – SEVERE AUTOIMMUNITY TRAITS IN A COLOMBIAN BOY: A NOVEL NRAS MUTATION C.182A>G (P.Q61R) CAUSING RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISEASE

VARGAS CELY F.S. – AN UNUSUAL CASE OF HEPATOMEGALY, PANCYTOPENIA AND AUTOINFLAMMATORY SYNDROME IN A COLOMBIAN GIRL: ABOUT A CASE OF PSTPIP1-ASSOCIATED MYELOID-RELATED PROTEINEMIA INFLAMMATORY SYNDROME

VÁSQUEZ P. – ASYMPTOMATIC SARS COV-2 INFECTION IN A 59 YEAR OLD WOMAN WITH AN AUTOINFLAMMATORY DISEASE DUE TO SOMATIC NLRC4 MOSAICISM

VENAVIDES W. – X- LINKED LYMPHOPROLIFERATIVE SYNDROME -1: ONE CASE IN A MILLION

VILLEGAS SILES M.F. – “DE NOVO” DETECTION OF TOTAL IGM AFTER A SARS COV2 INFECTION IN A PATIENT WITH COMMON VARIABLE IMMUNODEFICIENCY

ZHOU Z.Z. – THREE PATIENTS WITH SEVERE DEFECTS IN INTERFERON GAMMA RECEPTOR SIGNALING: A CHALLENGING DIAGNOSIS

– For additional information regarding poster display kindly reach out to:

Organising Secretariat:

AIM Group International – Lisbon Office
Av. Conde Valbom, 6 – 5º Lisbon, Portugal
Tel: +351 21 324 50 54/ 62 Fax: +351 21 324 50 51
Email: ipic5edition@aimgroup.eu

Read our news first!

Subscribe to our mailling list to stay tuned